Armstrong Advisory Group’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-63
| Closed | -$2.95K | – | 796 |
|
|
2024
Q1 | $2.95K | Hold |
63
| – | – | ﹤0.01% | 689 |
|
|
2023
Q4 | $2.95K | Hold |
63
| – | – | ﹤0.01% | 689 |
|
|
2023
Q3 | $2.53K | Sell |
63
-12
| -16% | -$482 | ﹤0.01% | 763 |
|
|
2023
Q2 | $7.99K | Buy |
75
+12
| +19% | +$1.28K | ﹤0.01% | 611 |
|
|
2023
Q1 | $18.7K | Hold |
63
| – | – | ﹤0.01% | 486 |
|
|
2022
Q4 | $21.5K | Buy |
+63
| New | +$21.5K | ﹤0.01% | 474 |
|